188 related articles for article (PubMed ID: 26338179)
21. Sclerosing Paragangliomas: Correlations of Histological Features with Patients' Genotype and Vesicular Monoamine Transporter Expression.
Pucci A; Bacca A; Barravecchia I; Di Stefano I; Belgio B; Lorenzini D; Torregrossa L; Chiacchio S; Congregati C; Materazzi G; Ferrari M; Angeloni D; Bernini G; Basolo F
Head Neck Pathol; 2022 Dec; 16(4):998-1011. PubMed ID: 35524772
[TBL] [Abstract][Full Text] [Related]
22. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
Hansson SR; Hoffman BJ; Mezey E
Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
Yao J; Erickson JD; Hersh LB
Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
[TBL] [Abstract][Full Text] [Related]
24. A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literature.
Kurisaki-Arakawa A; Saito T; Takahashi M; Mitani K; Yao T
Int J Clin Exp Pathol; 2014; 7(7):4438-47. PubMed ID: 25120831
[TBL] [Abstract][Full Text] [Related]
25. The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.
Anlauf M; Schafer MK; Depboylu C; Hartschuh W; Eiden LE; Kloppel G; Weihe E
J Histochem Cytochem; 2004 Jun; 52(6):779-88. PubMed ID: 15150286
[TBL] [Abstract][Full Text] [Related]
26. Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling.
Lohoff FW; Carr GV; Brookshire B; Ferraro TN; Lucki I
Brain Res; 2019 Jun; 1712():151-157. PubMed ID: 30685272
[TBL] [Abstract][Full Text] [Related]
27. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
28. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
Hansson SR; Mezey E; Hoffman BJ
Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
[TBL] [Abstract][Full Text] [Related]
29. Vesicular monoamine transporters (VMATs) in adrenal chromaffin cells: stress-triggered induction of VMAT2 and expression in epinephrine synthesizing cells.
Tillinger A; Sollas A; Serova LI; Kvetnansky R; Sabban EL
Cell Mol Neurobiol; 2010 Nov; 30(8):1459-65. PubMed ID: 21046458
[TBL] [Abstract][Full Text] [Related]
30. Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.
Saveanu A; Muresan M; De Micco C; Taieb D; Germanetti AL; Sebag F; Henry JF; Brunaud L; Enjalbert A; Weryha G; Barlier A
Endocr Relat Cancer; 2011 Apr; 18(2):287-300. PubMed ID: 21335363
[TBL] [Abstract][Full Text] [Related]
31. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
[TBL] [Abstract][Full Text] [Related]
32. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.
Alexander N; Marrano P; Thorner P; Naranjo A; Van Ryn C; Martinez D; Batra V; Zhang L; Irwin MS; Baruchel S
J Pediatr Hematol Oncol; 2019 Apr; 41(3):222-227. PubMed ID: 30334904
[TBL] [Abstract][Full Text] [Related]
34. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
[TBL] [Abstract][Full Text] [Related]
35. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
[TBL] [Abstract][Full Text] [Related]
36. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
[TBL] [Abstract][Full Text] [Related]
37. Erratum to: Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Parisi MT; Shulkin BL; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1396. PubMed ID: 27044383
[No Abstract] [Full Text] [Related]
38. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212
[TBL] [Abstract][Full Text] [Related]
39. Novel Meta-iodobenzylguanidine-Based Copper Thiosemicarbazide-1-guanidinomethylbenzyl Anticancer Compounds Targeting Norepinephrine Transporter in Neuroblastoma.
Zhang H; Xie F; Cheng M; Peng F
J Med Chem; 2019 Aug; 62(15):6985-6991. PubMed ID: 31283215
[TBL] [Abstract][Full Text] [Related]
40.
Turnock S; Turton DR; Martins CD; Chesler L; Wilson TC; Gouverneur V; Smith G; Kramer-Marek G
Sci Rep; 2020 Dec; 10(1):20918. PubMed ID: 33262374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
